News
UNDER TECHNOLOGY | Canadian researchers on promising path towards developing flu treatment using lipid target
Published: 24 May 2019
How can we help our immune system to balance the two main host defense strategies: attacking pathogens (called host resistance) and preserving our own tissue (called disease tolerance)? Dr. Erwan Pernet and Dr. Maziar Divangahi from te Research Institute of the Health Centre (RI-MUHC), have identified a lipid target to “tone down” the hyper-active immunity to influenza infection. Image credit: Health Centre
A team of scientists of the Research Institute of the Health Centre (RI-MUHC) in Montreal, Canada, has tackled this fundamental question and recently identified a target to “tone down” the hyper-active immunity to influenza infection.